Showing results (1141-1150 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|May 9, 2009
Evaluation of 5-hydroxy-2,3-diaryl (substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anti angiogenic and anticancer agentsVinod Kumar Sanna, Manu Jaggi, Vadlapudi Kumar, et al.Investigational New Drugs|May 13, 2009
Phase I trial of weekly docetaxel, weekly doxorubicin, daily oral cyclophosphamide, and G-CSF (ConTAC regimen) in advanced malignanciesRobert Wesolowski, David Peereboom, Patricia Weiss, et al.Investigational New Drugs|September 29, 2009
Structure-activity relationships between the Aconitum C20-diterpenoid alkaloid derivatives and the growth suppressive activities of Non-Hodgkin's lymphoma Raji cells and human hematopoietic stem/progenitor cellsMasaharu Hazawa, Kenji Takahashi, Koji Wada, et al.Investigational New Drugs|September 24, 2009
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumorsCharles J Nock, Joanna M Brell, Joseph A Bokar, et al.Investigational New Drugs|August 29, 2009
Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: results of a phase II, randomized, noncomparative studyDonald A Richards, Paul R Kuefler, Carlos Becerra, et al.Investigational New Drugs|August 26, 2009
MT7, a novel compound from a combinatorial library, arrests mitosis via inhibiting the polymerization of microtubulesZhixiang Zhang, Tao Meng, Jingxue He, et al.Investigational New Drugs|August 28, 2009
In vitro cytotoxic evaluation of novel dichlorodiorgano[N-(2-pyridylmethylene)arylamine]tin(IV) derivatives in human tumor cell linesTushar S Basu Baul, Dick de VosInvestigational New Drugs|July 9, 2009
A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancerSang Joon Shin, Hei-Cheul Jeung, Joong Bae Ahn, et al.Investigational New Drugs|September 5, 2009
Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cellsPay-Chin Leow, Quan Tian, Zhan-Yuin Ong, et al.Investigational New Drugs|August 12, 2009
Oral metronomic cyclophosphamide in elderly with metastatic melanomaEstelle Borne, Eve Desmedt, Alain Duhamel, et al.Pageof 372